H.R. 5585 - Advanced Research Projects Agency–Health Act

Bill Text

    Text of H.R. 5585 PDF XML

    (as reported)

    H. Rept. 117-365, Part 1 PDF

    Report from the Committee on Energy and Commerce to accompany H.R. 5585

Rule Information

COMMITTEE ACTION:
REPORTED BY A RECORD VOTE of 9-4 on Monday, June 21, 2022.

FLOOR ACTION ON H. RES. 1191: 
Agreed to by record vote of 214-202, after agreeing to the previous question by record vote of 215-200, on June 22, 2022.

MANAGERS: Ross/Burgess

1. Structured rule for H.R. 4176.
2. Provides one hour of general debate equally divided and controlled by the chair and ranking minority member of the Committee on Oversight and Reform or their designees.
3. Waives all points of order against consideration of the bill.
4. Provides that an amendment in the nature of a substitute consisting of the text of Rules Committee Print 117-52, modified by the amendment printed in part A of the Rules Committee report, shall be considered as adopted and the bill, as amended, shall be considered as read.
5. Waives all points of order against provisions in the bill, as amended.
6. Makes in order only those further amendments to H.R. 4176 printed in part B of the Rules Committee report. Each such amendment may be offered only in the order printed in the report, may be offered only by a Member designated in the report, shall be considered as read, shall be debatable for the time specified in the report equally divided and controlled by the proponent and an opponent, shall not be subject to amendment, and shall not be subject to a demand for division of the question.
7. Waives all points of order against the amendments printed in part B of the report.
8. Provides one motion to recommit.
9. Structured rule for H.R. 5585.
10. Provides one hour of general debate on the bill equally divided and controlled by the chair and ranking minority member of the Committee on Energy and Commerce or their designees.
11. Waives all points of order against consideration of the bill.
12. Provides that the amendment in the nature of a substitute recommended by the Committee on Energy and Commerce now printed in the bill shall be considered as adopted and the bill, as amended, shall be considered as read.
13. Waives all points of order against provisions in the bill, as amended.
14. Makes in order the further amendment to H.R. 5585 printed in part C of the Rules Committee report, if offered by the Member designated in the report, which shall be considered as read, shall be debatable for the time specified in the report equally divided and controlled by the proponent and an opponent, and shall not be subject to a demand for division of the question.
15. Waives all points of order against the amendment printed in part C of the Rules Committee report.
16. Provides one motion to recommit.

17. Structured rule for H.R. 7666.
18. Provides one hour of general debate on the bill equally divided and controlled by the chair and ranking minority member of the Committee on Energy and Commerce or their designees.
19. Waives all points of order against consideration of the bill.
20. Provides that an amendment in the nature of a substitute consisting of the text of Rules Committee Print 117-51, modified by the amendment printed in part D of the Rules Committee report, shall be considered as adopted and the bill, as amended, shall be considered as read.
21. Waives all points of order against provisions in the bill, as amended.
22. Provides that following debate, each further amendment printed in part E of the Rules Committee report not earlier considered as part of amendments en bloc pursuant to section 6 shall be considered only in the order printed in the report, may be offered only by a Member designated in the report, shall be considered as read, shall be debatable for the time specified in the report equally divided and controlled by the proponent and an opponent, may be withdrawn by the proponent at any time before the question is put thereon, shall not be subject to amendment, and shall not be subject to a demand for division of the question.
23. Section 6 provides that at any time after debate the chair of the Committee on Energy and Commerce or his designee may offer amendments en bloc consisting of further amendments printed in part E of the Rules Committee report not earlier disposed of. Amendments en bloc shall be considered as read, shall be debatable for 20 minutes equally divided and controlled by the chair and ranking minority member of the Committee on Energy and Commerce or their designees, shall not be subject to amendment, and shall not be subject to a demand for division of the question.
24. Waives all points of order against the amendments printed in part E of the report and amendments en bloc described in section 6 of the resolution.
25. Provides one motion to recommit.
26. Provides that House Resolution 188, agreed to March 8, 2021 (as most recently amended by House Resolution 1170, agreed to June 14, 2022), is amended by striking “June 22, 2022” each place it appears and inserting
(in each instance) “July 13, 2022”.
27. Provides that proceedings may be postponed through July 15, 2022, on measures that were the object of motions to suspend the rules on the legislative days of June 21, 2022, June 22, 2022, June 23, 2022, or June 24, 2022, and on which the yeas and nays were ordered.

Amendments (click headers to sort)

#Version #Sponsor(s)PartySummaryStatus
1Version 2Eshoo (CA), Guthrie (KY)Bi-PartisanRevised Clarifies organizational structure of offices within ARPA-H, limits the amount of administrative funding that may be used to operate ARPA-H to 15%, removes the requirement of Senate confirmation of Director, and clarifies ARPA-H's leasing authority.Made in Order
2Version 1Burgess (TX)RepublicanNothing in this Act or the amendments made by this Act shall be construed to impede or interfere in any way with the innovation, development, or distribution of transformative health technologies, including diagnostic tests for early disease detection and intervention.Submitted
3Version 1Perry (PA)RepublicanRequires the Director of ARPA-H to submit a quarterly report to Congress identifying all reimbursements made to the FDA.Submitted
4Version 1Perry (PA)RepublicanProhibits the Direct from hiring or appointing any federal employee who approves, or has approved, funding for gain-of-function research at the Wuhan Institute of Virology.Submitted
5Version 1Perry (PA)RepublicanAdds to the annual report from ARPA-H (1) description of all projects funded by ARPA-H with a vertebrate animal research component and their total cost including a complete abstract, animal species used, and the previous FY’s funding and (2) a detailed description of efforts to refine, reduce, and replace the use of animals in ARPA-H funded research, including with the use of new approach methodologies that may expedite medical advancements and save taxpayer dollars.Submitted